Discoveries over the past decade have revealed the power of microbes to prevent, diagnose and treat disease. As a result, clinical research and development in new therapies and diagnostics is rapidly advancing our understanding of how dysbiosis of the microbiome can result in disease and how prevention or reversal of microbial imbalances can be used in treatment. In this webinar, experts will address the possibilities as well as the challenges in this promising landscape.
Topics will include:
- Addressing operational, scientific, safety and endpoint challenges in trials evaluating the microbiome
- How to incorporate microbiome analysis into your study - taxonomy versus function; 16S, metagenomics and qPCR
- Quality, from manufacturing to clinical trials - GLP and CLIA/CAP
- Regulatory considerations and requirements